{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:36:48Z","timestamp":1792665408583,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s40257-018-0379-0","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:58:42Z","timestamp":1540861122000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0673-6724","authenticated-orcid":false,"given":"Abel","family":"Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"issue":"7","key":"379_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa1310460","volume":"370","author":"DL Morton","year":"2014","unstructured":"Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370(7):599\u2013609.","journal-title":"N Engl J Med"},{"key":"379_CR2","first-page":"872","volume":"2","author":"HL Snow","year":"1892","unstructured":"Snow HL. Melanotic cancerous disease. Lancet. 1892;2:872.","journal-title":"Lancet"},{"issue":"3","key":"379_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224(3):255\u201363 (discussion 63\u20136).","journal-title":"Ann Surg"},{"issue":"9105","key":"379_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351(9105):793\u20136.","journal-title":"Lancet"},{"issue":"11","key":"379_CR5","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2","volume":"49","author":"U Veronesi","year":"1982","unstructured":"Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49(11):2420\u201330.","journal-title":"Cancer"},{"issue":"9","key":"379_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","volume":"61","author":"FH Sim","year":"1986","unstructured":"Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61(9):697\u2013705.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"379_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392\u20139.","journal-title":"Arch Surg"},{"issue":"4","key":"379_CR8","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00000658-197710000-00010","volume":"186","author":"EC Holmes","year":"1977","unstructured":"Holmes EC, Moseley HS, Morton DL, Clark W, Robinson D, Urist MM. A rational approach to the surgical management of melanoma. Ann Surg. 1977;186(4):481\u201390.","journal-title":"Ann Surg"},{"issue":"1","key":"379_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0001-2998(00)80056-2","volume":"30","author":"DL Morton","year":"2000","unstructured":"Morton DL, Chan AD. The concept of sentinel node localization: how it started. Semin Nucl Med. 2000;30(1):4\u201310.","journal-title":"Semin Nucl Med"},{"issue":"16","key":"379_CR10","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19(16):3635\u201348.","journal-title":"J Clin Oncol"},{"issue":"4","key":"379_CR11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","volume":"238","author":"DL Morton","year":"2003","unstructured":"Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238(4):538\u201349 (discussion 49\u201350).","journal-title":"Ann Surg"},{"issue":"11","key":"379_CR12","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1002\/1097-0142(20010601)91:11<2110::AID-CNCR1239>3.0.CO;2-Q","volume":"91","author":"H Starz","year":"2001","unstructured":"Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91(11):2110\u201321.","journal-title":"Cancer"},{"issue":"16","key":"379_CR13","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1200\/JCO.2004.12.177","volume":"22","author":"DJ Dewar","year":"2004","unstructured":"Dewar DJ, Newell B, Green MA, Topping AP, Powell BW, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004;22(16):3345\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"379_CR14","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/SLA.0b013e31818fefe0","volume":"248","author":"AC Akkooi van","year":"2008","unstructured":"van Akkooi AC, Nowecki ZI, Voit C, Schafer-Hesterberg G, Michej W, de Wilt JH, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248(6):949\u201355.","journal-title":"Ann Surg"},{"issue":"1","key":"379_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1245\/ASO.2003.03.020","volume":"10","author":"ME Reeves","year":"2003","unstructured":"Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of nonsentinel lymph node status in melanoma. Ann Surg Oncol. 2003;10(1):27\u201331.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"379_CR16","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S1470-2045(16)00141-8","volume":"17","author":"U Leiter","year":"2016","unstructured":"Leiter U, Stadler R, Mauch C, Hohenberger W, Brockmeyer N, Berking C, et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(6):757\u201367.","journal-title":"Lancet Oncol"},{"issue":"23","key":"379_CR17","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","volume":"376","author":"MB Faries","year":"2017","unstructured":"Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, et al. Completion dissection or observation for sentinel-node metastasis in melanoma. N Engl J Med. 2017;376(23):2211\u201322.","journal-title":"N Engl J Med"},{"issue":"19","key":"379_CR18","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","volume":"375","author":"AM Eggermont","year":"2016","unstructured":"Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, et al. Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy. N Engl J Med. 2016;375(19):1845\u201355.","journal-title":"N Engl J Med"},{"issue":"19","key":"379_CR19","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","volume":"377","author":"J Weber","year":"2017","unstructured":"Weber J, Mandala M, Del Vecchio M, Gogas HJ, Arance AM, Cowey CL, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med. 2017;377(19):1824\u201335.","journal-title":"N Engl J Med"},{"issue":"19","key":"379_CR20","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","volume":"377","author":"GV Long","year":"2017","unstructured":"Long GV, Hauschild A, Santinami M, Atkinson V, Mandal\u00e0 M, Chiarion-Sileni V, et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. N Engl J Med. 2017;377(19):1813\u201323.","journal-title":"N Engl J Med"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-018-0379-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-0379-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T21:39:35Z","timestamp":1662327575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-018-0379-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":20,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["379"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-0379-0","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]},"assertion":[{"value":"30 October 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Medical writing assistance was funded by Laboratoires dermatologiques Av\u00e8ne. Abel Gonzalez received funds from Laboratoires dermatologiques Av\u00e8ne for presenting at the conference.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Abel Gonzalez declares that he has no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is published as part of a journal supplement wholly funded by Laboratoires dermatologiques Av\u00e8ne.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}